Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics Buys an Illumina Genome Analzyer

NEW YORK (GenomeWeb News) – Ambry Genetics said Friday that it has purchased a Genome Analyzer from Illumina that it plans to use in conducting pharmacogenomics services for customers.
 
The Aliso Viejo, Calif.-based genetic testing firm said that it has already begun running research samples on the GA with its probe capture technology.
 
“To date we’ve run assays with hundreds of genes on the probe capture technology; with new bioinformatics software, SNP annotation and exon identification, we’ve been able to find many novel mutations,” Ambry CEO Charles Dunlop said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.